Analyses of the Effect of Baseline Age on the Efficacy and Safety of Siponimod in Patients with Active SPMS from the Phase 3 EXPAND Study

被引：0
|
作者：
Hua, Le H. [1 ]
Bar-Or, Amit [2 ]
Lublin, Fred [3 ]
Meng, Xiangyi [4 ]
Su, Wendy
Cree, Bruce A. C. [5 ]
Fox, Robert J. [6 ]
机构：
[1] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Cleveland, OH 44106 USA
[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[4] Novartis Pharmaceut, Bangalore, Karnataka, India
[5] Univ Calif San Francisco, UCSF Weill Inst Neurosci, San Francisco, CA 94143 USA
[6] Cleveland Clin, Cleveland, OH 44106 USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
4747
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Analyses Of The Effect Of Baseline Age On The Efficacy And Safety Of Siponimod In Patients With Active SPMS From The Expand Study
    Hua, L.
    Bar-Or, A.
    Lublin, F. D.
    Meng, X.
    Su, W.
    Cree, A.
    Fox, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 29 - 29
  • [2] Analyses of the Effect of Disease Duration on the Efficacy and Safety of Siponimod in Patients with Active SPMS from the Phase 3 EXPAND Study
    Cohan, Stanley L.
    Bar-Or, Amit
    Coyle, Patricia K.
    Lublin, Fred D.
    Meng, Xiangyi
    Su, Wendy
    Cree, Bruce A. C.
    [J]. NEUROLOGY, 2021, 96 (15)
  • [3] Effects of baseline age and disease duration on the efficacy and safety of siponimod in patients with active SPMS: Post hoc analyses from the EXPAND study
    Hua, Le H.
    Bar-Or, Amit
    Cohan, Stanley L.
    Lublin, Fred
    Coyle, Patricia K.
    Cree, Bruce A. C.
    Meng, Xiangyi
    Su, Wendy
    Cox, Gina Mavrikis
    Fox, Robert J.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 75
  • [4] Analyses Of The Effect Of Disease Duration On The Efficacy And Safety Of Siponimod In Patients With Active SPMS From The Expand Study
    Bar-Or, A.
    Cohan, S. L.
    Coyle, P. K.
    Lublin, F. D.
    Meng, X.
    Su, W.
    Cree, B. A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 29 - 30
  • [5] Analyses of the effect of baseline age on the efficacy and safety of siponimod in patients with active secondary progressive multiple sclerosis from the EXPAND study
    Hua, L. H.
    Bar-Or, A.
    Lublin, F. D.
    Meng, X.
    Cox, G. M.
    Cree, B. Ac
    Fox, R. J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 551 - 552
  • [6] Siponimod improves cognitive processing speed in patients with SPMS: Results from Phase 3 EXPAND Study
    Benedict, R. H.
    Cree, B.
    Tomic, D.
    Fox, R.
    Giovannoni, G.
    Bar-or, A.
    Gold, R.
    Vermersch, P.
    Pohlmann, H.
    Karlsson, G.
    Dahlke, F.
    Kappos, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 432 - 432
  • [7] Safety and efficacy of siponimod in patients with active secondary progressive multiple sclerosis identifying as Hispanic from the phase 3 EXPAND study
    Cohan, S.
    Hua, L. H.
    Bar-Or, A.
    Lublin, F. D.
    Meng, X.
    Cox, G. M.
    Coyle, P. K.
    Fox, R. J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 590 - 591
  • [8] Dynamics of progression to wheelchair in SPMS and impact of siponimod: Subgroup analyses from the EXPAND study
    Vermersch, P.
    Arnould, S.
    Gold, R.
    Kappos, L.
    Fox, R.
    Bar-Or, A.
    Cree, B.
    Ansari, S.
    Meier, D. Piani
    Karlsson, G.
    Rouyrre, N.
    Giovannoni, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 207 - 208
  • [9] Effect of Siponimod on Cognition in Patients with Secondary Progressive Multiple Sclerosis (SPMS): Phase 3 EXPAND Study Subgroup Analysis
    Benedict, Ralph
    Fox, Robert
    Tomic, Davorka
    Cree, Bruce
    Vermersch, Patrick
    Giovannoni, Gavin
    Bar-Or, Amit
    Gold, Ralf
    Ritter, Shannon
    Karlsson, Goeril
    Wolf, Christian
    Kappos, Ludwig
    [J]. NEUROLOGY, 2019, 92 (15)
  • [10] Siponimod delays the time to wheelchair in patients with SPMS: results from the EXPAND study
    Vermersch, P.
    Gold, R.
    Kappos, L.
    Fox, R.
    Bar-Or, A.
    Cree, B.
    Rouyrre, N.
    Arnould, S.
    Dahlke, F.
    Karlsson, G.
    Giovannoni, G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 55 - 56
12345